ROYCE & ASSOCIATES LP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 50 filers reported holding MERSANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$7,000
+16.7%
419
+22.5%
0.00%
Q4 2017$6,0003420.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders